Trial Profile
Phase2 study of perioperative XELOX in patients with locally-advanced lower rectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 25 Jun 2019 Status changed from active, no longer recruiting to completed.
- 21 Jun 2012 New trial record